Berlin, Germany

Michael Unbehauen

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dendropharm Gmbh. Active years: 2022.


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Unbehauen: Innovator in Analgesic Preparations

Introduction

Michael Unbehauen is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of analgesics, particularly through his innovative use of nanocarriers in pharmaceutical compositions. His work aims to enhance the efficacy of pain relief while minimizing side effects.

Latest Patents

Unbehauen holds a patent for an "Analgesic preparation with nanocarriers and use thereof." This invention focuses on a pharmaceutical composition that includes a hyperbranched polymer nanocarrier, such as a dendritic polymer or dendrimer. The composition is designed to deliver an analgesic, preferably an opioid like nalbuphine, which primarily exerts a peripheral effect. This approach is intended to reduce the side effects associated with central or intestinal opioid receptor activation, making it particularly useful for treating peripheral pain and inflammation. He has 1 patent to his name.

Career Highlights

Unbehauen is associated with Dendropharm GmbH, where he continues to develop innovative solutions in the pharmaceutical industry. His work is characterized by a commitment to improving patient outcomes through advanced drug delivery systems.

Collaborations

Some of his notable coworkers include Florian Paulus and Emanuel Fleige, who contribute to the collaborative efforts at Dendropharm GmbH.

Conclusion

Michael Unbehauen's contributions to the field of analgesics through his innovative patent demonstrate his dedication to enhancing pain management therapies. His work continues to pave the way for advancements in pharmaceutical compositions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…